AstraZeneca has agreed to pay $26 million to settle litigation involving the atypical antipsychotic, Seroquel. The South Carolina Attorney General had been after the company to reimburse state taxpayers for the off-label use of Seroquel. The company, along with other drugmakers, had challenged states that hire product liability attorneys on contingency […]
Author: Cal Warriner
Virtually all Rejuvenate and ABG II patients have received notice from their doctor that the devices have been recalled. These patients are all now faced with the prospect of a painful and risky revision surgery. Rejuvenate and ABG II victims can basically be placed into three categories. I know. I’ve […]
[two_third_last]The more we uncover cases such as this one, the angrier we get. Back in 1992, twenty years ago, an article in The Journal of Arthroplasty, showed that a 76-year-old man implanted with a hip prosthesis made of metals and plastic stimulated an adverse reaction that required the hip to […]
This study comes from the Karolinska Institute in Sweden and was reported in the Journal of Bone and Joint Surgery in July 1991. Researchers studied nine uncemented hip prostheses that had been revised (removed). In four of the nine hips, researchers found tissue discoloration and corrosion at the head-neck junction. […]
If you were attending the recent FDA gathering of expert scientists, orthopaedic device developers, and surgeons who implant total hip replacements (THR), you would leave believing that the issue of early failures and metal toxicity from artificial hips was a new development. But a closer look at science from the […]
It used to be that the arms industry was the bad boy of all industries. Move over! Big Pharma has now topped the gun trade with a $3 billion fine imposed on GlaxoSmithKline (GSK). Britain’s largest pharmaceutical company, GSK, was just busted for offering lavish incentives to doctors to promote […]
On July 4, 2012, Stryker posted on its website a national recall of its Rejuvenate and ADM hip implant systems. It’s obvious that Stryker has received far too many reports of shockingly premature failures of its hip implant. The Rejuvenate has only been on the market since 2009 so enough […]
Documents recently posted to the FDA’s website say pharmaceutical company, Amylin, has not been completely forthcoming about its diabetes drug, Byetta, and related drug Bydureon, concerning their potential for cardiovascular complications. The active ingredient is the same in the two drugs which are both used to treat type 2 diabetes. However, Bydureon […]
The Searcy Denney Mass Tort Unit would like to thank our client, Howard Sadwin of Sarasota, Florida, for his poignant statements today before the Orthopaedic and Rehabilitation Devices Panel of the Medical Devices Advisory Committee for the Food and Drug Administration. The hearings were convened in Gaithersburg, Maryland. In addition […]
As a Stryker hip implant attorney, I have written previously about our experience with clients who had Stryker hip replacement problems. Most of these clients tell us about conversations with their doctors before surgery in which they were told the Rejuvenate hip was better for them due to their young […]
